Dr. Lal PathLabs First in India to Use AI for Cancer Diagnosis

India is experiencing a revolution in the diagnostic industry with Dr. Lal PathLabs becoming the first lab in the country to utilize deep learning based artificial intelligence module to detect lymph node metastasis including micro-metastasis in pati

DavaIndia Set to Expand Nationwide With Tech-Driven Growth

In the next years, DavaIndia, a private generic pharmacy retail chain owned by Gujarat-based Zota Healthcare, plans to grow from its existing 1,600 locations to over 3,000

AnGes, Boehringer Partner to Develop PAD Drug Ingredient

A contract development and manufacturing agreement has been signed between AnGes Inc. and Boehringer Ingelheim, a biopharmaceutical business involved in both human and animal health, for the drug ingredient of AnGes' experimental treatment for

P D Hinduja Hospital and Medical Research Centre Launches First of its Kind Dedicated Geriatric Clinic on World Senior Citizen Day 2025

On the occasion of World Senior Citizen’s Day 2025, P. D. Hinduja Hospital & Medical Research Centre today inaugurated its first-of-its-kind dedicated Geriatric Clinic committed to providing comprehensive care for senior citizens

NATCO Pharma Launches Bosentan Oral Suspension in US with 180-Day Edge

NATCO Pharma Limited has announced the launch of Bosentan tablets for oral suspension (TFOS), 32 mg, in the United States.

Pharma Compliance Software 2025 :Smarter Solutions for Regulatory Success

Pharma compliance software is significant for Pharmaceutical regulations, and it set to become newer and more complex in 2025. Many companies are adopting advanced compliance software to help streamline compliance gained by multilayered requirements

Foxconn Invests in Robocore Ahead of Planned IPO

Robocore Technology Limited (Robocore), a member of the Hong Kong Science and Technology Parks Corporation (HKSTP) Partner Programme, announced that it has recently completed its Series D funding

Alembic Pharma Gets USFDA Nod for Pulmonary Hypertension Drug Macitentan

Alembic Pharmaceuticals Limited announced that the US Food and Drug Administration (USFDA) gave its final approval to their Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg.

Natureoroma Launches Squacare Gel for Oral Submucous Fibrosis Patients

Natureoroma, based in Ramanagaram in the south of Bengaluru, has made Squacare, a gel for the mouth, made to help folks with oral submucous fibrosis (OSMF).

Accord BioPharma Launches Imuldosa Prefilled Syringes at Lowest WAC

Accord BioPharma, Inc., the U.S. arm of Intas Pharmaceuticals, Ltd., has rolled out Imuldosa (ustekinumab-srlf), a match to Stelara (ustekinumab). Sold in ready-to-use syringes and vials, Imuldosa hits the market with the lowest cost

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.